Active Pharmaceutical Ingredient/ API Market

Active Pharmaceutical Ingredient/ API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone, Biosimilar) Drug (OTC, Rx), Therapy, and Region - Global Forecast to 2024

Report Code: PH 1262 Jan, 2019, by marketsandmarkets.com

[253 Pages Report] The global APIs market is estimated to reach USD 245.2 billion by 2024 from USD 182.2 billion in 2019, at a CAGR of 6.1% during the forecast period. The increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals are some of the major factors driving the growth of the global APIs market. On the other hand, the unfavorable drug price control policies across various countries and the increasing penetration of counterfeit drugs are expected to restrain the growth of this market in the coming years.

In 2019, the prescription drugs segment is expected to account for the largest share of the APIs market.

Based on the type of drug, the APIs market can be classified into two segments prescription drugs and over-the-counter (OTC) drugs. In 2019, the prescription drugs segment is expected to account for the largest share of the APIs market. The demand for drugs falling under this category has increased significantly in recent years due to the rising prevalence of target diseases. Additionally, the largest share of the prescription drugs segment can also be attributed to the increased focus of innovator companies on the development of specialty drugs and affordability of healthcare. The implementation of significant federal reforms to improve the affordability of healthcare, especially in the US, has expanded the consumption of both traditional and specialty drugs. Also, inflation has played a key role in enhancing revenue from the sales of prescription drugs, particularly specialty drugs. All these factors are collectively responsible for the large share of this segment.

The captive API manufacturers segment is expected to account for the largest share of the global APIs market in 2019.

Based on type of manufacturer, the APIs market can be divided into captive API manufacturers and merchant API manufacturers. In 2019, the captive API manufacturers segment is expected to account for the largest share of the APIs market. This can be attributed to the fact that most big pharmaceutical companies possess their API manufacturing facilities and are vertically integrated across the pharmaceutical supply chain. Moreover, innovator companies prefer in-house manufacturing of innovative products to avail economic benefit and prevent technology leakage.

The mammalian expression systems segment is expected to account for the largest share of the biotech APIs market in 2019.

On the basis of expression system, biotech APIs can be categorized into mammalian expression systems, microbial expression systems, yeast expression systems, insect expression systems, and other expression systems. The biotech APIs market, by expression system, is dominated by mammalian expression systems owing to their ability to achieve the highest level of post-translational modifications and efficient protein folding, which makes them suitable for human use.

North America is expected to account for the largest market size during the forecast period.

Geographically, the active pharmaceutical ingredients market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2019, North America is expected to dominate the market, followed by Europe. The major factors driving the overall growth of the APIs market in this region include the growing incidence of preventable chronic diseases, increasing government focus on generic drugs, rising demand for biologics and specialty drugs, and technological advancements in the manufacturing processes of APIs. This market segment is expected to grow at a modest rate due to a combination of economic and healthcare severity measures and the introduction of low-cost, generic versions of branded drugs.

Key players in the global APIs market

The global APIs market is competitive in nature, with several big as well as emerging players. The prominent players in the market are Pfizer, Inc. (US), Novartis AG (Switzerland), Sanofi (France), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (US), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (US), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), AbbVie Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), and AstraZeneca plc (UK).

Pfizer is one of the leading players in the global API industry. The leading position of the company is majorly attributed to its exhaustive product portfolio. The company has a strong brand image, which gives it a competitive edge over other players. In order to remain competitive and strengthen its market position, the company primarily focuses on adopting both organic and inorganic growth strategies such as agreements, partnerships, collaborations, product approvals, and acquisitions. In accordance with this, in June 2016, Pfizer acquired Anacor Pharmaceuticals, Inc. (US), a leading biopharmaceutical company developing small molecule therapeutics.

Recent Developments

  • In January 2018, Pfizer entered into a collaboration with Sangamo Therapeutics, Inc. (US) for the development of a potential gene therapy to treat amyotrophic lateral sclerosis (ALS).
  • In May 2018, Novartis acquired AveXis, a clinical-stage gene therapy company, to develop a gene-based treatment for spinal muscular atrophy.
  • In January 2018, Sanofi acquired Ablynx, a biopharmaceutical company to strengthen its platform for growth in rare blood disorders.
  • In January 2018, Sanofi and Alnylam Pharmaceuticals, Inc. (US) announced a strategic restructuring of their RNAi therapeutics alliance to streamline and optimize the development and commercialization of products prescribed for the treatment of rare genetic diseases.

Key Questions addressed by the report

  • Where will all these developments take the industry in the mid to long term?
  • What types of annual and multi-year partnerships are API companies exploring?
  • Which are the key players in the market and how intense is the competition?
  • Which are the recent contracts and agreements key players have signed?
  • What are the recent trends affecting the API manufacturers?

Table of Contents

1 Introduction (Page No. - 26)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 30)
    2.1 Research Data
           2.1.1 Secondary Sources
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Sources
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 39)

4 Premium Insights (Page No. - 44)
    4.1 Active Pharmaceutical Ingredients: Market Overview
    4.2 Active Pharmaceutical Ingredients Market, By Type
    4.3 Active Pharmaceutical Ingredients Market, By Type of Manufacturer
    4.4 Active Pharmaceutical Ingredients Market, By Type  of Synthesis
    4.5 Active Pharmaceutical Ingredients Market, By Type  of Drug
    4.6 Geographic Snapshot: Active Pharmaceutical Ingredients Market

5 Market Overview (Page No. - 48)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Incidence of Chronic Diseases
                    5.2.1.2 Technological Advancements in API Manufacturing
                    5.2.1.3 Growing Importance of Generics
                    5.2.1.4 Increasing Uptake of Biopharmaceuticals
                    5.2.1.5 Growing Adoption of Artificial Intelligence-Based Tools for Drug Discovery
                    5.2.1.6 Adoption of Organ-On-Chip Models in Drug Development
                    5.2.1.7 Growing Focus on Precision Medicine
                    5.2.1.8 Growing Investments in Real-World Evidence By Pharmaceutical Companies
           5.2.2 Restraints
                    5.2.2.1 Unfavorable Drug Price Control Policies Across Various Countries
                    5.2.2.2 Increasing Penetration of Counterfeit Drugs
           5.2.3 Opportunities
                    5.2.3.1 Emerging Biosimilars Market
                    5.2.3.2 Highly Potent Active Pharmaceutical Ingredients
                    5.2.3.3 Emerging Markets
                    5.2.3.4 Emerging Technologies
           5.2.4 Challenges
                    5.2.4.1 Product Differentiation - A Major Concern for API Manufacturers
                    5.2.4.2 High Manufacturing Costs

6 Active Pharmaceutical Ingredients Market, By Type (Page No. - 59)
    6.1 Introduction
    6.2 Innovative Active Pharmaceutical Ingredients
           6.2.1 Growing Number of New Molecular Entities Gaining Regulatory Approval to Drive Market Growth
    6.3 Generic Active Pharmaceutical Ingredients
           6.3.1 Government Initiatives Supporting the Adoption of Generic Drugs to Boost Market Growth

7 Active Pharmaceutical Ingredients Market,  By Type of Manufacturer (Page No. - 64)
    7.1 Introduction
    7.2 Captive API Manufacturers
           7.2.1 High Manufacturing Flexibility and Assurance of Product Quality Have Driven Focus on Captive Manufacturing
    7.3 Merchant API Manufacturers
           7.3.1 Merchant API Manufacturers Market, By Type
                    7.3.1.1 Merchant Innovative API Manufacturers
                               7.3.1.1.1 Impending Patent Expiries and Increasing Costs of Innovative Drugs May Restrain Market Growth
                    7.3.1.2 Merchant Generic API Manufacturers
                               7.3.1.2.1 Low Manufacturing Cost of Generics Likely to Drive the Growth of This Segment
           7.3.2 Merchant API Manufacturers Market, By Type of Synthesis
                    7.3.2.1 Merchant Synthetic API Manufacturers
                               7.3.2.1.1 Need for Specialized Manufacturing Capabilities has Resulted in Expansion Among Market Players in This Segment
                    7.3.2.2 Merchant Biotech API Manufacturers
                               7.3.2.2.1 Complexity of Manufacturing Biotech APIs has Driven Focus on Partnerships Between Companies and CMOS

8 Active Pharmaceutical Ingredients Market,  By Type of Synthesis (Page No. - 74)
    8.1 Introduction
    8.2 Synthetic Active Pharmaceutical Ingredients
           8.2.1 Synthetic Active Pharmaceutical Ingredients Market,  By Type
                    8.2.1.1 Innovative Synthetic APIs
                               8.2.1.1.1 The High Value of Innovative APIs to Drive the Growth of This Segment
                    8.2.1.2 Generic Synthetic APIs
                               8.2.1.2.1 Initiatives to Promote the Penetration of Generics to Bring Down Healthcare Costs—A Major Growth Driver
    8.3 Biotech Active Pharmaceutical Ingredients
           8.3.1 Biotech Active Pharmaceutical Ingredients Market, By Type
                    8.3.1.1 Innovative Biotech APIs
                               8.3.1.1.1 Growing Demand for Innovative Biopharmaceuticals to Drive the Market for This Segment
                    8.3.1.2 Generic Biotech APIs
                               8.3.1.2.1 Increasing Demand for Biosimilar Drugs Due to Their Cost-Effectiveness to Drive the Growth of This Segment
           8.3.2 Biotech Active Pharmaceutical Ingredients Market,  By Product
                    8.3.2.1 Monoclonal Antibodies
                               8.3.2.1.1 Growing Applications of Antibody-Drug Conjugates in the Treatment of Cancer to Drive the Growth of This Segment
                    8.3.2.2 Hormones & Growth Factors
                               8.3.2.2.1 The Growing Incidence of Hormonal Disorders to Drive the Market for This Segment
                    8.3.2.3 Cytokines
                               8.3.2.3.1 Interferons and Interleukins Boost the Immune System and Have Important Applications in Cancer Treatment
                    8.3.2.4 Fusion Proteins
                               8.3.2.4.1 Growing Applications of Fc Fusion Proteins in Biopharmaceuticals to Drive the Growth of This Segment
                    8.3.2.5 Recombinant Vaccines
                               8.3.2.5.1 Growing Prevalence of Infectious Diseases has Boosted Vaccine Development—A Positive Indicator of Growth
                    8.3.2.6 Therapeutic Enzymes
                               8.3.2.6.1 Growing Significance of Enzymes in Therapies for Cancer and Pain Management to Drive the Growth of This Segment
                    8.3.2.7 Blood Factors
                               8.3.2.7.1 Growing Incidence of Hemophilia to Drive the Growth of This Segment
           8.3.3 Biotech Active Pharmaceutical Ingredients Market,  By Expression System
                    8.3.3.1 Mammalian Expression Systems
                               8.3.3.1.1 Ability of These Systems to Carry Post-Translational Modification to Drive the Market for This Segment
                    8.3.3.2 Microbial Expression Systems
                               8.3.3.2.1 Ability of These Expression Systems to Provide High Expression Levels of Proteins to Drive the Market for This Segment
                    8.3.3.3 Yeast Expression Systems
                               8.3.3.3.1 Advantages Such as Efficient Protein Secretion, Simple Purification, and Endotoxin-Free Products to Boost Demand
                    8.3.3.4 Insect Expression Systems
                               8.3.3.4.1 Efficient Post-Translational Modifications Provided By These Systems to Boost Their Demand
                    8.3.3.5 Other Expression Systems

9 Active Pharmaceutical Ingredients Market,  By Type of Drug (Page No. - 96)
    9.1 Introduction
    9.2 Prescription Drugs
           9.2.1 Growing Disease Prevalence is Expected to Drive the Prescription Drugs Market
    9.3 Over-The-Counter Drugs
           9.3.1 Sales of Otc Drugs Have Risen Due to Innovations, Promotion of Self-Medication, and Increased Access
    9.4 Active Pharmaceutical Ingredients Market, By Potency
           9.4.1 Low-To-Moderate Potency Active Pharmaceutical Ingredients
           9.4.2 Potent-To-Highly Potent Active Pharmaceutical Ingredients

10 Active Pharmaceutical Ingredients Market,  By Therapeutic Application (Page No. - 103)
     10.1 Introduction
     10.2 Communicable Diseases
             10.2.1 Global Health Impact of Communicable Diseases and Increasing Antimicrobial Resistance—Key Market Drivers
     10.3 Oncology
             10.3.1 Increase in Global Spending on Cancer Medication to Boost the Market for This Segment
     10.4 Pain Management
             10.4.1 Increasing Demand for Innovative and Advanced Pain Medications is A Major Growth Driver for This Market
     10.5 Cardiovascular Diseases
             10.5.1 Growing Incidence of Cardiovascular Diseases Owing to Sedentary Lifestyles is A Major Growth Driver
     10.6 Diabetes
             10.6.1 High Global Prevalence of Diabetes to Drive the Growth of This Segment
     10.7 Respiratory Diseases
             10.7.1 High Global Prevalence of Respiratory Diseases to Drive the Growth of This Segment
     10.8 Other Therapeutic Applications

11 Active Pharmaceutical Ingredients Market, By Region (Page No. - 113)
     11.1 Introduction
     11.2 North America
             11.2.1 US
                        11.2.1.1 Increasing Expenditure on Medicine is Expected to Drive the APIs Market in the Us
             11.2.2 Canada
                        11.2.2.1 Support From Government Organizations is Driving the Growth of the APIs Market in Canada
     11.3 Europe
             11.3.1 Germany
                        11.3.1.1 Germany to Dominate the Market in Europe
             11.3.2 France
                        11.3.2.1 Emergence of Pharmerging Markets in Asia May Hinder Market Growth in France
             11.3.3 UK
                        11.3.3.1 Growing Adoption of Generics Will Drive the Growth of the UK Market
             11.3.4 Italy
                        11.3.4.1 Italy’s Share in the Global Merchant APIs Market is Expected to Remain Stable Over the Forecast Period
             11.3.5 Spain
                        11.3.5.1 Spanish Market has Been Typically Dominated By Branded Drugs
             11.3.6 Rest of Europe
     11.4 Asia
             11.4.1 Japan
                        11.4.1.1 Japanese Government Aims to Boost the Use of Generics By 2020
             11.4.2 China
                        11.4.2.1 Government Policies to Increase Medicine Access and Affordability Will Support Market Growth
             11.4.3 India
                        11.4.3.1 India is A Leading Producer of Generics
             11.4.4 South Korea
                        11.4.4.1 Government Initiatives to Introduce Full Medical Coverage for Major Chronic Diseases Likely to Drive This Market
             11.4.5 Rest of Asia
     11.5 Rest of the World

12 Competitive Landscape (Page No. - 200)
     12.1 Overview
     12.2 Market Player Ranking
     12.3 Competitive Leadership Mapping
             12.3.1 Vanguards
             12.3.2 Dynamic Differentiators
             12.3.3 Innovators
             12.3.4 Emerging Players
     12.4 Competitive Situation and Trends
             12.4.1 Product Launches
             12.4.2 Expansions
             12.4.3 Acquisitions
             12.4.4 Other Strategies

13 Company Profiles (Page No. - 209)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     13.1 Pfizer, Inc.
     13.2 Novartis AG
     13.3 Sanofi
     13.4 Boehringer Ingelheim
     13.5 Bristol-Myers Squibb
     13.6 Teva Pharmaceutical Industries Ltd.
     13.7 Eli Lilly and Company
     13.8 Glaxosmithkline PLC
     13.9 Merck & Co., Inc.
     13.10 Abbvie Inc.
     13.11 F. Hoffmann-La Roche
     13.12 Astrazeneca

*Details on Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 246)
     14.1 Discussion Guide
     14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.3 Available Customizations
     14.4 Related Reports
     14.5 Author Details


List of Tables (245)

Table 1 Indicative List of Drugs Going Generic in 2018
Table 2 Indicative List of Biologics That Gained Regulatory Approval  in the US in 2017–2018
Table 3 Indicative List of Biosimilars That Gained US Regulatory Approval in 2018
Table 4 Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 5 Indicative List of New Molecular Entities That Gained US Fda Approval in 2018
Table 6 List of Major Drugs Set to Lose Patent Protection in 2018
Table 7 Innovative Active Pharmaceutical Ingredients Market, By Region,  2017–2024 (USD Billion)
Table 8 Generic Active Pharmaceutical Ingredients Market, By Region, 2017–2024 (USD Billion)
Table 9 Active Pharmaceutical Ingredients Market, By Type of Manufacturer,  2017–2024 (USD Billion)
Table 10 Captive API Manufacturers Market, By Region, 2017–2024 (USD Billion)
Table 11 List of Significant Cmo/Cdmo Facility Expansions
Table 12 Merchant API Manufacturers Market, By Region, 2017–2024 (USD Billion)
Table 13 Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 14 Merchant Innovative API Manufacturers Market, By Region, 2017–2024 (USD Billion)
Table 15 Merchant Generic API Manufacturers Market, By Region, 2017–2024 (USD Billion)
Table 16 Merchant API Manufacturers Market, By Type of Synthesis  2017–2024 (USD Billion)
Table 17 Merchant Synthetic API Manufacturers Market, By Region, 2017–2024 (USD Billion)
Table 18 Merchant Biotech API Manufacturers Market, By Region, 2017–2024 (USD Billion)
Table 19 Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 20 Synthetic Active Pharmaceutical Ingredients Market, By Region, 2017–2024 (USD Billion)
Table 21 Synthetic Active Pharmaceutical Ingredients Market, By Type  2017–2024 (USD Billion)
Table 22 Innovative Synthetic Active Pharmaceutical Ingredients Market, By Region, 2017–2024 (USD Billion)
Table 23 Generic Synthetic Active Pharmaceutical Ingredients Market, By Region, 2017–2024 (USD Billion)
Table 24 Top Selling Biologics (2018)
Table 25 Biotech Active Pharmaceutical Ingredients Market, By Region, 2017–2024 (USD Billion)
Table 26 Biotech Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 27 Innovative Biotech Active Pharmaceutical Ingredients Market, By Region, 2017–2024 (USD Billion)
Table 28 Indicative List of Biosimilars That Gained US Fda Approval During 2017–2018
Table 29 Generic Biotech Active Pharmaceutical Ingredients Market, By Region, 2017–2024 (USD Billion)
Table 30 Biotech Active Pharmaceutical Ingredients Market, By Product  2017–2024 (USD Billion)
Table 31 Indicative List of Monoclonal Antibodies That Received Fda Approval in 2018
Table 32 Biotech Active Pharmaceutical Ingredients Market for Monoclonal Antibodies, By Region, 2017–2024 (USD Billion)
Table 33 Biotech Active Pharmaceutical Ingredients Market for Hormones & Growth Factors, By Region, 2017–2024 (USD Billion)
Table 34 Biotech Active Pharmaceutical Ingredients Market for Cytokines, By Region, 2017–2024 (USD Billion)
Table 35 Biotech Active Pharmaceutical Ingredients Market for Fusion Proteins,  By Region, 2017–2024 (USD Billion)
Table 36 Biotech Active Pharmaceutical Ingredients Market for Recombinant Vaccines, By Region, 2017–2024 (USD Million)
Table 37 Biotech Active Pharmaceutical Ingredients Market for Therapeutic Enzymes, By Region, 2017–2024 (USD Million)
Table 38 Biotech Active Pharmaceutical Ingredients Market for Blood Factors,  By Region, 2017–2024 (USD Million)
Table 39 Biotech Active Pharmaceutical Ingredients Market, By Expression System, 2017–2024 (USD Billion)
Table 40 Biotech Active Pharmaceutical Ingredients Market for Mammalian Expression Systems, By Region, 2017–2024 (USD Billion)
Table 41 Biotech Active Pharmaceutical Ingredients Market for Microbial Expression Systems, By Region, 2017–2024 (USD Billion)
Table 42 Biotech Active Pharmaceutical Ingredients Market for Yeast Expression Systems, By Region, 2017–2024 (USD Billion)
Table 43 Biotech Active Pharmaceutical Ingredients Market for Insect Expression Systems, By Region, 2017–2024 (USD Billion)
Table 44 Biotech Active Pharmaceutical Ingredients Market for Other Expression Systems, By Region, 2017–2024 (USD Million)
Table 45 Active Pharmaceutical Ingredients Market, By Type of Drug, 2017–2024 (USD Billion)
Table 46 Prescription Drugs Market, By Region, 2017–2024 (USD Billion)
Table 47 Over-The-Counter Drugs Market, By Region, 2017-2024 (USD Billion)
Table 48 Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 49 Active Pharmaceutical Ingredients Market, By Therapeutic Application,  2017–2024 (USD Billion)
Table 50 Indicative List of US Fda-Approved Drugs for Communicable Diseases (2018)
Table 51 Active Pharmaceutical Ingredients Market for Communicable Diseases,  By Region, 2017–2024 (USD Billion)
Table 52 Indicative List of US Fda-Approved Drugs for Oncology (2018)
Table 53 Active Pharmaceutical Ingredients Market for Oncology, By Region, 2017–2024 (USD Billion)
Table 54 Indicative List of US Fda-Approved Drugs for Pain Management (2018)
Table 55 Active Pharmaceutical Ingredients Market for Pain Management, By Region, 2017–2024 (USD Billion)
Table 56 Active Pharmaceutical Ingredients Market for Cardiovascular Diseases,  By Region, 2017–2024 (USD Billion)
Table 57 Active Pharmaceutical Ingredients Market for Diabetes, By Region,  2017–2024 (USD Billion)
Table 58 Active Pharmaceutical Ingredients Market for Respiratory Diseases,  By Region, 2017–2024 (USD Billion)
Table 59 Active Pharmaceutical Ingredients Market for Other Therapeutic Applications, By Region, 2017–2024 (USD Billion)
Table 60 Active Pharmaceutical Ingredients Market, By Region, 2017–2024 (USD Billion)
Table 61 North America: Active Pharmaceutical Ingredients Market, By Country, 2017–2024 (USD Billion)
Table 62 North America: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 63 North America: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 64 North America: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 65 North America: Merchant API Manufacturers Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 66 North America: Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 67 North America: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 68 North America: Biotech Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 69 North America: Biotech Active Pharmaceutical Ingredients Market, By Product, 2017–2024 (USD Billion)
Table 70 North America: Active Pharmaceutical Ingredients Market, By Type of Drug, 2017–2024 (USD Billion)
Table 71 North America: Active Pharmaceutical Ingredients Market, By Potency,  2017–2024 (USD Billion)
Table 72 North America: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 73 Indicative List of Recent Fda Approvals for Drug Delivery Products
Table 74 US: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 75 US: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 76 US: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 77 US: Merchant API Manufacturers Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 78 US: Active Pharmaceutical Ingredients Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 79 US: Synthetic Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 80 US: Biotech Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 81 US: Active Pharmaceutical Ingredients Market, By Type of Drug, 2017–2024 (USD Billion)
Table 82 US: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 83 US: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 84 Canada: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 85 Canada: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 86 Canada: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 87 Canada: Merchant API Manufacturers Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 88 Canada: Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 89 Canada: Synthetic Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 90 Canada: Biotech Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 91 Canada: Active Pharmaceutical Ingredients Market, By Type of Drug,  2017–2024 (USD Billion)
Table 92 Canada: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 93 Canada: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 94 Europe: Active Pharmaceutical Ingredients Market, By Country, 2017–2024 (USD Billion)
Table 95 Europe: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 96 Europe: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 97 Europe: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 98 Europe: Merchant API Manufacturers Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 99 Europe: Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 100 Europe: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 101 Europe: Biotech Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 102 Europe: Biotech Active Pharmaceutical Ingredients Market, By Product, 2017–2024 (USD Billion)
Table 103 Europe: Active Pharmaceutical Ingredients Market, By Type of Drug,  2017–2024 (USD Billion)
Table 104 Europe: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 105 Europe: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 106 Germany: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 107 Germany: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 108 Germany: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 109 Germany: Merchant API Manufacturers Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 110 Germany: Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 111 Germany: Synthetic Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 112 Germany: Biotech Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 113 Germany: Active Pharmaceutical Ingredients Market, By Type of Drug,  2017–2024 (USD Billion)
Table 114 Germany: Active Pharmaceutical Ingredients Market, By Potency,  2017–2024 (USD Billion)
Table 115 Germany: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 116 France: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 117 France: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 118 France: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 119 France: Merchant API Manufacturers Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 120 France: Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 121 France: Synthetic Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 122 France: Biotech Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 123 France: Active Pharmaceutical Ingredients Market, By Type of Drug,  2017–2024 (USD Billion)
Table 124 France: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 125 France: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 126 UK: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 127 UK: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 128 UK: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 129 UK: Merchant API Manufacturers Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 130 UK: Active Pharmaceutical Ingredients Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 131 UK: Synthetic Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 132 UK: Biotech Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 133 UK: Active Pharmaceutical Ingredients Market, By Type of Drug, 2017–2024 (USD Billion)
Table 134 UK: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 135 UK: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 136 Italy: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 137 Italy: Active Pharmaceutical Ingredients Market, By Type of  Manufacturer, 2017–2024 (USD Billion)
Table 138 Italy: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 139 Italy: Merchant API Manufacturers Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 140 Italy: Active Pharmaceutical Ingredients Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 141 Italy: Synthetic Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 142 Italy: Biotech Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 143 Italy: Active Pharmaceutical Ingredients Market, By Type of Drug,  2017–2024 (USD Billion)
Table 144 Italy: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 145 Italy: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 146 Spain: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 147 Spain: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 148 Spain: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 149 Spain: Merchant API Manufacturers Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 150 Spain: Active Pharmaceutical Ingredients Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 151 Spain: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 152 Spain: Biotech Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Million)
Table 153 Spain: Active Pharmaceutical Ingredients Market, By Type of Drug,  2017–2024 (USD Billion)
Table 154 Spain: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Million)
Table 155 Spain: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Million)
Table 156 RoE: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 157 RoE: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 158 RoE: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 159 RoE: Merchant API Manufacturers Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 160 RoE: Active Pharmaceutical Ingredients Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 161 RoE: Synthetic Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 162 RoE: Biotech Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 163 RoE: Active Pharmaceutical Ingredients Market, By Type of Drug, 2017–2024 (USD Billion)
Table 164 RoE: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 165 RoE: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 166 Asia: Active Pharmaceutical Ingredients Market, By Country, 2017–2024 (USD Billion)
Table 167 Asia: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 168 Asia: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 169 Asia: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 170 Asia: Merchant API Manufacturers Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 171 Asia: Active Pharmaceutical Ingredients Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 172 Asia: Synthetic Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 173 Asia: Biotech Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 174 Asia: Biotech Active Pharmaceutical Ingredients Market, By Product,  2017–2024 (USD Million)
Table 175 Asia: Active Pharmaceutical Ingredients Market, By Type of Drug,  2017–2024 (USD Billion)
Table 176 Asia: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 177 Asia: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 178 Japan: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 179 Japan: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 180 Japan: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 181 Japan: Merchant API Manufacturers Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 182 Japan: Active Pharmaceutical Ingredients Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 183 Japan: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 184 Japan: Biotech Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 185 Japan: Active Pharmaceutical Ingredients Market, By Type of Drug,  2017–2024 (USD Billion)
Table 186 Japan: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 187 Japan: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 188 China: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 189 China: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 190 China: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 191 China: Merchant API Manufacturers Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 192 China: Active Pharmaceutical Ingredients Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 193 China: Synthetic Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 194 China: Biotech Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 195 China: Active Pharmaceutical Ingredients Market, By Type of Drug,  2017–2024 (USD Billion)
Table 196 China: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 197 China: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 198 India: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 199 India: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 200 India: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 201 India: Merchant API Manufacturers Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 202 India: Active Pharmaceutical Ingredients Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 203 India: Synthetic Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 204 India: Biotech Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 205 India: Active Pharmaceutical Ingredients Market, By Type of Drug,  2017–2024 (USD Billion)
Table 206 India: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 207 India: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 208 South Korea: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 209 South Korea: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 210 South Korea: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 211 South Korea: Merchant API Manufacturers Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 212 South Korea: Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 213 South Korea: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 214 South Korea: Biotech Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 215 South Korea: Active Pharmaceutical Ingredients Market, By Type of Drug, 2017–2024 (USD Billion)
Table 216 South Korea: Active Pharmaceutical Ingredients Market, By Potency,  2017–2024 (USD Billion)
Table 217 South Korea: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 218 RoA: Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 219 RoA: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 220 RoA: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 221 RoA: Merchant API Manufacturers Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 222 RoA: Active Pharmaceutical Ingredients Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 223 RoA: Synthetic Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 224 RoA: Biotech Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 225 RoA: Active Pharmaceutical Ingredients Market, By Type of Drug, 2017–2024 (USD Billion)
Table 226 RoA: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 227 RoA: Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2017–2024 (USD Billion)
Table 228 RoW: Active Pharmaceutical Ingredients Market,  By Type, 2017–2024 (USD Billion)
Table 229 RoW: Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017–2024 (USD Billion)
Table 230 RoW: Merchant API Manufacturers Market, By Type, 2017–2024 (USD Billion)
Table 231 RoW: Merchant API Manufacturers Market, By Type of Synthesis, 2017–2024 (USD Billion)
Table 232 RoW: Active Pharmaceutical Ingredients Market, By Type of Synthesis,  2017–2024 (USD Billion)
Table 233 RoW: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2017–2024 (USD Billion)
Table 234 RoW: Biotech Active Pharmaceutical Ingredients Market, By Type,  2017–2024 (USD Billion)
Table 235 RoW: Active Pharmaceutical Ingredients Market, By Type of Drug,  2017–2024 (USD Billion)
Table 236 RoW: Active Pharmaceutical Ingredients Market, By Potency, 2017–2024 (USD Billion)
Table 237 RoW: Active Pharmaceutical Ingredients Market, By Therapeutic  Application, 2017–2024 (USD Billion)
Table 238 Active Pharmaceutical Ingredients Market Player Ranking, 2018
Table 239 Product Launches, 2016–2018
Table 240 Expansions, 2016–2018
Table 241 Acquisitions, 2015–2018
Table 242 Other Strategies, 2015–2018
Table 243 Exchange Rate (Utilized for the Conversion of Eur to USD)
Table 244 Exchange Rate (Utilized for the Conversion of Gbp to USD)
Table 245 Exchange Rates (Utilized for the Conversion of Chf to USD)


List of Figures (41 Figures)

Figure 1 APIs: Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Active Pharmaceutical Ingredients Market, By Type,  2019 vs 2024 (USD Billion)
Figure 8 Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2019 vs 2024
Figure 9 Active Pharmaceutical Ingredients Market, By Type of Synthesis,  2019 vs 2024
Figure 10 Biotech Active Pharmaceutical Ingredients Market, By Product,  2019 vs 2024
Figure 11 Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2019 vs 2024
Figure 12 Geographical Snapshot of the Active Pharmaceutical Ingredients Market
Figure 13 Increasing Incidence of Chronic Diseases and Growing Importance of Generics are Driving Market Growth
Figure 14 Generic APIs to Grow at the Highest CAGR From 2019 to 2024
Figure 15 Merchant API Manufacturers Segment to Register the Highest Growth During the Forecast Period
Figure 16 Oncology Segment to Grow at the Highest CAGR During the Forecast Period
Figure 17 Prescription Drugs to Command the Largest Market Share in 2019
Figure 18 China to Witness the Highest Growth Rate During the Forecast Period
Figure 19 Active Pharmaceutical Ingredients Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Innovative Active Pharmaceutical Ingredients Segment to Dominate the Market in 2019
Figure 21 Captive Manufacturers Segment to Dominate the Market in 2019
Figure 22 Synthetic APIs to Dominate the Active Pharmaceutical Ingredients Market During the Forecast Period
Figure 23 Active Pharmaceutical Ingredients Market, By Type of Drug
Figure 24 Low-To-Moderate Segment to Dominate the Active Pharmaceutical Ingredients Market, By Potency, in 2019
Figure 25 Communicable Diseases to Dominate the Active Pharmaceutical Ingredients Market in 2019
Figure 26 North America: Market Snapshot
Figure 27 Europe: Market Snapshot
Figure 28 Expansions—Key Growth Strategy Adopted By Market Players From 2015 to October 2018
Figure 29 Competitive Leadership Mapping of the Active Pharmaceutical Ingredients Market
Figure 30 Pfizer, Inc.: Company Snapshot (2017)
Figure 31 Novartis AG: Company Snapshot (2017)
Figure 32 Sanofi: Company Snapshot (2017)
Figure 33 Boehringer Ingelheim: Company Snapshot (2017)
Figure 34 Bristol-Myers Squibb: Company Snapshot (2017)
Figure 35 Teva Pharmaceutical Industries Ltd.: Company Snapshot (2017)
Figure 36 Eli Lilly and Company: Company Snapshot (2017)
Figure 37 Glaxosmithkline PLC: Company Snapshot (2017)
Figure 38 Merck & Co., Inc.: Company Snapshot (2017)
Figure 39 Abbvie Inc.: Company Snapshot (2017)
Figure 40 F. Hoffmann-La Roche: Company Snapshot (2017)
Figure 41 Astrazeneca: Company Snapshot (2017)

The study involved four major activities to estimate the current size of the global active pharmaceutical ingredients market. Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the global active pharmaceutical ingredients market. Secondary sources include directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers; and annual reports were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Following is the breakdown of primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the global active pharmaceutical ingredients market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The revenue generated from the sale of active pharmaceutical ingredients by leading players has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global APIs market on the basis of type, type of manufacturer, type of synthesis, type of drug, therapeutic application, and region
  • To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to the individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, joint ventures, alliances, mergers & acquisitions, approvals, expansions, and R&D activities in the global APIs market.

Scope of the Report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

Type, type of manufacturer, type of synthesis, type of drug, therapeutic application, and region.

Geographies covered

North America (US & Canada), Asia, Europe (Germany, UK, France, & RoE), and the Rest of the World

Companies covered

Pfizer, Inc. (US), Novartis AG (Switzerland), Sanofi (France), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (US), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (US), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), AbbVie Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), and AstraZeneca plc (UK)

The research report categorizes the global APIs market into the following segments and subsegments:

APIs Market, by Type

  • Innovative APIs
  • Generic APIS

APIs Market, by Type of Manufacturer

  • Captive API Manufacturers
  • Merchant API Manufacturers
  • Merchant API Manufacturers Market, by Type
    • Merchant Innovative API Manufacturers
    • Merchant Generic API Manufacturers
    • Merchant API Manufacturers Market, by Type of Synthesis
    • Merchant Synthetic API Manufacturers
    • Merchant Biotech API Manufacturers

APIs market, by Type of Synthesis

  • Synthetic APIs Market
    • l Synthetic APIs Market, by Type
      • Innovative Synthetic APIs
      • Generic Synthetic APIs
  • Biotech APIs Market
    • l Biotech APIs Market, by Type
      • Innovative Biotech APIs
      • Generic Biotech APIs
    • l Biotech APIs Market, by Product
      • Monoclonal Antibodies
      • Hormones and Growth Factors
      • Cytokines
      • Fusion Proteins
      • Therapeutic Enzymes
      • Recombinant Vaccines
      • Blood Factors
    • l Biotech APIs Market, by Expression System
      • Mammalian Expression Systems
      • Microbial Expression Systems
      • Yeast Expression Systems
      • Insect Expression Systems
      • Other Expression Systems

APIs Market, by Type of Drug

  • Prescription Drugs
  • Over-the-counter Drugs

APIs Market, by Therapeutic Application

  • Communicable Diseases
  • Oncology
  • Diabetes
  • Cardiovascular Diseases
  • Pain Management
  • Respiratory Diseases
  • Other Therapeutic Applications

API Market, by Region

  • North America
    • l US
    • l Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia
    • Japan
    • China
    • India
    • South Korea
    • Rest of Asia (RoA)
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.

The following customization options are available for this report.

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
PH 1262
Published ON
Jan, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Active Pharmaceutical Ingredient/ API Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home